Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Hoarding by Government Continues While Expensive New Medications for Covid Are Unavailable, States the Association of American Physicians and Surgeons (AAPS)

TUCSON, Ariz., Jan. 17, 2022 (GLOBE NEWSWIRE) -- The Association of American Physicians and Surgeons (AAPS) condemns the continued hoarding by the federal government of hydroxychloroquine, which it has kept in a stockpile while expensive new medications for Covid remain mostly unavailable.

The first 10 million doses of the new Pfizer medication Paxlovid ordered by the federal government will not be available until June. Only 250,000 courses of treatment will be accessible by the end of January, which is too little, too late.

Meanwhile, since early last year the federal government has hoarded more than 60 million doses of hydroxychloroquine donated by generous pharmaceutical companies trying to help stem the Covid-19 pandemic. Rather than release these to the public as intended by the donors, the federal government has wrongly withheld this medication, instead promoting vaccination as the only answer. AAPS unsuccessfully attempted to get government to release the stockpile in a lawsuit filed in June 2020.

“Why has the government been touting a medication that is mostly unavailable, while withholding from the public a medication that was donated for use against Covid?” asks Jane Orient, M.D., Executive Director of AAPS. “No one is helped by promoting an expensive new treatment that patients cannot obtain,” Dr. Orient added.

The State of New York received Paxlovid doses for treating only about 20,000 people. Its Health Commissioner Dr. Mary Bassett observed that that is insufficient.

Merck’s pill for Covid, molnupiravir, will be accessible sooner but reportedly might cause birth defects, and thus is not first among the government’s recommendations. “Why is the government recommending a new medication that may be unsafe for many?” Dr. Orient asks. “Hydroxychloroquine, in contrast, was FDA approved for safety in 1955 and has been safely used by hundreds of millions of people.”

In addition, the government recently began to ration access to monoclonal antibodies. More than 2 years into the pandemic, hospitals report that they can treat many fewer patients with antibodies now compared with at the height of the pandemic last year.

The Association of American Physicians and Surgeons (AAPS) is a national organization representing physicians in all specialties since 1943. Its motto is omnia pro aegroto (everything for the patient).

Contact: Jane M. Orient, M.D., (520) 323-3110, [email protected]


Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).